Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

EyePoint Pharmaceuticals, Inc. - Common Stock (NQ:EYPT)

11.45 +0.43 (+3.86%)
Streaming Delayed Price Updated: 10:21 AM EST, Nov 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 195,428
Open 10.92
Bid (Size) 11.41 (200)
Ask (Size) 11.48 (100)
Prev. Close 11.02
Today's Range 10.86 - 11.45
52wk Range 3.910 - 14.91
Shares Outstanding 34,984,044
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
EyePoint (EYPT) Q3 2025 Earnings Call Transcript
EyePoint (EYPT) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
EyePoint Pharmaceuticals Inc (NASDAQ:EYPT) Shares Drop on Q3 Earnings and Revenue Miss
EyePoint Pharmaceuticals stock falls after Q3 2025 earnings miss estimates. Despite the financial setback, its key DURAVYU trials for wet AMD are fully enrolled and on track for 2026 data. 
Via Chartmill
Topics Earnings

Performance

YTD
+42.5%
+42.5%
1 Month
-16.0%
-16.0%
3 Month
+8.2%
+8.2%
6 Month
+87.9%
+87.9%
1 Year
-1.4%
-1.4%

More News

Read More
Earnings Scheduled For November 5, 2025
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
EyePoint Pharmaceuticals Raises Capital As It Advances Lead Product To Pivotal Study
Via Benzinga
Earnings Scheduled For August 6, 2025
Via Benzinga
Analyst Expectations For EyePoint Pharmaceuticals's Future
Via Benzinga
Earnings Scheduled For May 7, 2025
Via Benzinga
A Peek at EyePoint Pharmaceuticals's Future Earnings
Via Benzinga
EyePoint (EYPT) Q2 Revenue Drops 44%
Via The Motley Fool
EyePoint Pharmaceuticals Inc (NASDAQ:EYPT) Q2 2025 Earnings Miss Estimates as Shares Drop 4.5% Pre-Market
Via Chartmill
Topics Earnings
Forecasting The Future: 4 Analyst Projections For EyePoint Pharmaceuticals
Via Benzinga
Breakout Momentum Plays You May Not Know About
Via MarketBeat
Heico, Monro, Abercrombie & Fitch, Joby Aviation And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Demystifying EyePoint Pharmaceuticals: Insights From 4 Analyst Reviews
Via Benzinga
Analyst Ratings For EyePoint Pharmaceuticals
Via Benzinga
Li Auto, Xponential Fitness And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
Earnings Scheduled For March 5, 2025
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
These stocks are moving in today's pre-market session
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
EyePoint's Investigational Drug Shows Early And Sustained Improvement Than Regeneron's Eylea For Diabetes-Associated Vision Loss
Via Benzinga
PROCEPT BioRobotics Posts Strong Q3 Earnings, Joins Monte Rosa Therapeutics, EyePoint Pharmaceuticals And Other Big Stocks Moving Higher On Monday
Via Benzinga
NVIDIA, Trump Media & Technology, Bausch + Lomb, Sirius XM And Other Big Stocks Moving Higher On Monday
Via Benzinga
Topics Government

Frequently Asked Questions

Is EyePoint Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, EyePoint Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does EyePoint Pharmaceuticals, Inc. - Common Stock trade on?
EyePoint Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for EyePoint Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for EyePoint Pharmaceuticals, Inc. - Common Stock is EYPT on the Nasdaq Stock Market
What is the current price of EyePoint Pharmaceuticals, Inc. - Common Stock?
The current price of EyePoint Pharmaceuticals, Inc. - Common Stock is 11.45
When was EyePoint Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of EyePoint Pharmaceuticals, Inc. - Common Stock was at 11/06/25 10:21 AM ET
What is the market capitalization of EyePoint Pharmaceuticals, Inc. - Common Stock?
The market capitalization of EyePoint Pharmaceuticals, Inc. - Common Stock is 400.39M
How many shares of EyePoint Pharmaceuticals, Inc. - Common Stock are outstanding?
EyePoint Pharmaceuticals, Inc. - Common Stock has 400M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.